Comparing Nova Eye Medical (ELXMF) & Its Rivals
to related companies based on the strength of its analyst recommendations, profitability, valuation, earnings, dividends, risk and institutional ownership. Nova Eye Medical is a publicly-traded company in the 'Medical Devices' industry. It has a strong analyst recommendations, profitability, valu
How does it compare to its competitors? Nova Eye Medical will be compared to other similar businesses on the basis of their profitability, risk, value, analyst recommendations and dividends.
Value & Earnings
This table compares Nova Eye Medical with its competitors in terms of gross revenue, earnings-per-share (EPS) and valuation.
Gross Revenue
Net Income
Price/Earnings ratio
Nova Eye Medical
N/A
N/A
13.70
Nova Eye Medical Competitors
$526.78 Million
13.60 Million Dollars
70.88
Rivals of Nova Eye Medical have higher earnings and revenue than Nova Eye Medical. Nova Eye Medical's price-to earnings ratio is lower than that of its competitors, which indicates it is more affordable.
Profitability
This table compares Nova Eye Medical's net margins with those of its competitors, as well as their return on equity and assets.
Net Margins
Return on Equity
Return on Assets
Nova Eye Medical
N/A
N/A
N/A
Nova Eye Medical Competitors
-70.95%
-38.06%
-15.68%
Insiders & Institutional Ownership
Institutional investors own 12.4% of Nova Eye Medical's shares. Comparatively 30.2% shares of all "Medical Devices" companies are owned institutional investors. Insiders own 22.7% shares in all "Medical Devices" companies. A high level of institutional ownership indicates that hedge funds and large money managers, as well as endowments, believe the company will perform better than the market in the long run.
Analyst Ratings
MarketBeat has provided a list of the current ratings and recommendations for Nova Eye Medical.
Sell Ratings
Hold Ratings
Buy Ratings
Strong Buy Ratings
Rating Score
Nova Eye Medical
0
0
0
0
N/A
Nova Eye Medical Competitors
245
963
1493
68
2.50
Grouped together, the 'Medical Devices’ companies could see a potential gain of 57.66%. Analysts believe Nova Eye Medical is less likely to grow than its competitors, given the higher potential upside of their rivals.
You can read more about it here:
Nova Eye Medical's rivals have beaten Nova Eye Medical in 5 out of 8 comparison factors.
Nova Eye Medical Company Profile
(
Get Free Report
)
Nova Eye Medical Limited is a company that designs, develops and distributes surgical devices to treat glaucoma. They also sell, market, service, and maintain these devices. The company's products include iTrack, a surgical device for reducing intraocular pressure in adults with open-angle glaucoma, iTrack Advanced, a natural ocular draining system, Molteno3, a glaucoma-drainage device that treats patients with severe or complicated glaucoma, and 2RT, a proprietary technology used to treat early/intermediate macular degeneration. The company operates in Australia as well as the United States, Europe and Asia Pacific. Nova Eye Medical Limited was previously known as Ellex Medical Lasers Limited. It changed its name in July 2020. MarketBeat.com offers a FREE daily email newsletter
.